$201.24 Million in Sales Expected for Cross Country Healthcare, Inc. (CCRN) This Quarter

Equities analysts predict that Cross Country Healthcare, Inc. (NASDAQ:CCRN) will announce sales of $201.24 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Cross Country Healthcare’s earnings, with the lowest sales estimate coming in at $199.92 million and the highest estimate coming in at $202.80 million. Cross Country Healthcare posted sales of $219.67 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 8.4%. The company is expected to announce its next quarterly earnings results on Wednesday, February 27th.

According to Zacks, analysts expect that Cross Country Healthcare will report full year sales of $816.83 million for the current financial year, with estimates ranging from $815.50 million to $818.38 million. For the next financial year, analysts expect that the company will post sales of $832.90 million, with estimates ranging from $821.16 million to $839.80 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings data on Thursday, November 1st. The business services provider reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Cross Country Healthcare had a return on equity of 4.43% and a net margin of 3.67%. The company had revenue of $200.72 million for the quarter, compared to analyst estimates of $200.66 million. During the same quarter in the previous year, the business earned $0.23 earnings per share. The company’s revenue was down 12.2% on a year-over-year basis.

A number of brokerages recently commented on CCRN. Zacks Investment Research upgraded shares of Cross Country Healthcare from a “sell” rating to a “hold” rating in a report on Monday, August 27th. ValuEngine upgraded shares of Cross Country Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, August 23rd. Lake Street Capital upgraded shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $10.00 to $12.00 in a report on Friday, November 2nd. Barrington Research restated an “outperform” rating on shares of Cross Country Healthcare in a report on Thursday, August 9th. Finally, BidaskClub lowered shares of Cross Country Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, September 13th. Nine research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $12.29.

Shares of NASDAQ:CCRN traded down $0.51 during midday trading on Tuesday, reaching $8.55. 158,600 shares of the company were exchanged, compared to its average volume of 252,272. Cross Country Healthcare has a fifty-two week low of $7.41 and a fifty-two week high of $14.49. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 0.35. The firm has a market cap of $328.79 million, a price-to-earnings ratio of 14.23, a PEG ratio of 4.68 and a beta of 0.63.

Institutional investors have recently added to or reduced their stakes in the stock. Mackay Shields LLC bought a new position in Cross Country Healthcare in the second quarter valued at $451,000. Citadel Advisors LLC grew its position in Cross Country Healthcare by 193.0% in the second quarter. Citadel Advisors LLC now owns 264,940 shares of the business services provider’s stock valued at $2,981,000 after purchasing an additional 174,530 shares in the last quarter. Systematic Financial Management LP grew its position in Cross Country Healthcare by 53.2% in the second quarter. Systematic Financial Management LP now owns 634,924 shares of the business services provider’s stock valued at $7,143,000 after purchasing an additional 220,357 shares in the last quarter. Royce & Associates LP grew its position in Cross Country Healthcare by 2.8% in the second quarter. Royce & Associates LP now owns 1,060,481 shares of the business services provider’s stock valued at $11,930,000 after purchasing an additional 28,500 shares in the last quarter. Finally, Seizert Capital Partners LLC bought a new position in Cross Country Healthcare in the third quarter valued at $406,000. 91.28% of the stock is owned by institutional investors and hedge funds.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Recommended Story: What are the most popular ETFs

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit